Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00889681 · ClinicalTrials.gov registry record · NA

Continued Access Protocol

A NA study of Atrial Fibrillation, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
NA
Development phase
81
Enrollment target
10
Study locations

NCT00889681 is a NA study of Atrial Fibrillation that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 81 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00889681, a NA study of Atrial Fibrillation, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
10
Study locations

Study Summary

This Continued Access Protocol has been written to allow ongoing treatment of subjects at selected investigational sites while the marketing application for the Arctic Front® Cryoablation System is under review. This study will also allow collection of additional safety data following modifications implemented into the Arctic Front® Catheter and Cryoablation System.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE Arctic Front Cardiac Cryoablation System

Study Locations (10)

California

  • Cedars Sinai Medical Center - Los Angeles
  • Stanford Hospital & Clinical - Stanford

Virginia

  • Inova Research Center - Falls Church
  • Virginia Commonwealth University Health System - Richmond

Arizona

  • Banner Good Samaritan - Phoenix

Florida

  • Bay Heart Group - Tampa

Georgia

  • Piedmont Hospital - Atlanta

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

Texas

  • Baylor Heart & Vascular Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2009-03
Est. Completion 2013-10
Phase NA

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00889681

The ClinicalTrials.gov registry entry for NCT00889681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Arctic Front Cardiac Cryoablation System is the first listed.

NCT00889681 reports 10 study locations spanning 8 distinct geographic areas - top geographies include California, Virginia, Arizona.

Frequently Asked Questions

What is clinical trial NCT00889681 about?

NCT00889681 is a clinical study titled "Continued Access Protocol". This Continued Access Protocol has been written to allow ongoing treatment of subjects at selected investigational sites while the marketing application for the Arctic Front® Cryoablation System is under review. This study will also allow collection of additional safety data following modifications ...

What is the current status of trial NCT00889681?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2009-03. Estimated completion is 2013-10.

What conditions does trial NCT00889681 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT00889681?

The interventions under investigation include: Arctic Front Cardiac Cryoablation System (DEVICE).

Who is sponsoring clinical trial NCT00889681?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00889681 being conducted?

This trial has 10 study locations across Arizona, California, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.